Follow
Juan Carlos Montero
Juan Carlos Montero
Institute of Biomedical Research of Salamanca (IBSAL). Instituto de Biología Molecular y Celular del
Verified email at usal.es
Title
Cited by
Cited by
Year
Extracellular signal-regulated kinase phosphorylates tumor necrosis factor α-converting enzyme at threonine 735: a potential role in regulated shedding
E Díaz-Rodríguez, JC Montero, A Esparís-Ogando, L Yuste, A Pandiella
Molecular biology of the cell 13 (6), 2031, 2002
4062002
Inhibition of SRC family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors
JC Montero, S Seoane, A Ocaña, A Pandiella
Clinical cancer research 17 (17), 5546-5552, 2011
3072011
Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2
A Esparís-Ogando, E Díaz-Rodríguez, JC Montero, L Yuste, P Crespo, ...
Molecular and cellular biology 22 (1), 270-285, 2002
2202002
Differential shedding of transmembrane neuregulin isoforms by the tumor necrosis factor-α-converting enzyme
JC Montero, L Yuste, E Dı́az-Rodrı́guez, A Esparı́s-Ogando, A Pandiella
Molecular and Cellular Neuroscience 16 (5), 631-648, 2000
2152000
Expression of Erk5 in early stage breast cancer and association with disease free survival identifies this kinase as a potential therapeutic target
JC Montero, A Ocana, M Abad, MJ Ortiz-Ruiz, A Pandiella, ...
PloS one 4 (5), e5565, 2009
1432009
Neuregulins and cancer
JC Montero, R Rodríguez-Barrueco, A Ocaña, E Díaz-Rodríguez, ...
Clinical cancer research 14 (11), 3237-3241, 2008
1432008
Multifunctional role of Erk5 in multiple myeloma
X Carvajal-Vergara, S Tabera, JC Montero, A Esparís-Ogando, ...
Blood 105 (11), 4492-4499, 2005
1192005
Aplidin, a marine organism–derived compound with potent antimyeloma activity in vitro and in vivo
CS Mitsiades, EM Ocio, A Pandiella, P Maiso, C Gajate, M Garayoa, ...
Cancer research 68 (13), 5216-5225, 2008
1152008
P-Rex1 participates in Neuregulin-ErbB signal transduction and its expression correlates with patient outcome in breast cancer
JC Montero, S Seoane, A Ocaña, A Pandiella
Oncogene 30 (9), 1059-1071, 2011
1052011
Zalypsis: a novel marine-derived compound with potent antimyeloma activity that reveals high sensitivity of malignant plasma cells to DNA double-strand breaks
EM Ocio, P Maiso, X Chen, M Garayoa, S Alvarez-Fernandez, ...
Blood, The Journal of the American Society of Hematology 113 (16), 3781-3791, 2009
1042009
Activation of ErbB2 by overexpression or by transmembrane neuregulin results in differential signaling and sensitivity to herceptin
L Yuste, JC Montero, A Esparís-Ogando, A Pandiella
Cancer research 65 (15), 6801-6810, 2005
1022005
Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer
JC Montero, A Esparís-Ogando, MF Re-Louhau, S Seoane, M Abad, ...
Oncogene 33 (2), 148-156, 2014
932014
The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotype
E Colado, S Álvarez-Fernández, P Maiso, J Martín, MB Vidriales, ...
Ferrata Storti Foundation, 2008
912008
In vivo murine model of acquired resistance in myeloma reveals differential mechanisms for lenalidomide and pomalidomide in combination with dexamethasone
EM Ocio, D Fernández-Lázaro, L San-Segundo, L López-Corral, ...
Leukemia 29 (3), 705-714, 2015
892015
Stimulation of cleavage of membrane proteins by calmodulin inhibitors
E DÍAZ-RODRÍGUEZ, A ESPARÍS-OGANDO, JC MONTERO, L YUSTE, ...
Biochemical Journal 346 (2), 359-367, 2000
862000
Neuregulin expression modulates clinical response to trastuzumab in patients with metastatic breast cancer
E de Alava, A Ocana, M Abad, JC Montero, A Esparís-Ogando, ...
Journal of Clinical Oncology 25 (19), 2656-2663, 2007
842007
Transforming growth factor‐β1 induces collagen synthesis and accumulation via p38 mitogen‐activated protein kinase (MAPK) pathway in cultured L6E9 myoblasts
A Rodrıguez-Barbero, J Obreo, L Yuste, JC Montero, A Rodrı́guez-Peña, ...
FEBS letters 513 (2-3), 282-288, 2002
742002
Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer
MM Noblejas-López, C Nieto-Jimenez, M Burgos, M Gómez-Juárez, ...
Journal of Experimental & Clinical Cancer Research 38, 1-9, 2019
732019
Mitogen-activated protein kinase-dependent and-independent routes control shedding of transmembrane growth factors through multiple secretases
JC Montero, L Yuste, E Díaz-Rodríguez, A Esparís-Ogando, A Pandiella
Biochemical Journal 363 (2), 211-221, 2002
722002
Cleavage of the TrkA neurotrophin receptor by multiple metalloproteases generates signalling‐competent truncated forms
E Díaz‐Rodríguez, N Cabrera, A Esparís‐Ogando, JC Montero, ...
European Journal of Neuroscience 11 (4), 1421-1430, 1999
701999
The system can't perform the operation now. Try again later.
Articles 1–20